148 related articles for article (PubMed ID: 3291440)
1. [Clinical aspects of erythema migrans (Lyme) borreliosis].
Weber K
Z Hautkr; 1988 Apr; 63(4):314-9. PubMed ID: 3291440
[TBL] [Abstract][Full Text] [Related]
2. Dermatological manifestations of Lyme borreliosis.
Mullegger RR
Eur J Dermatol; 2004; 14(5):296-309. PubMed ID: 15358567
[TBL] [Abstract][Full Text] [Related]
3. Comments on the course and classification of Lyme borreliosis.
Asbrink E; Hovmark A
Scand J Infect Dis Suppl; 1991; 77():41-3. PubMed ID: 1947810
[TBL] [Abstract][Full Text] [Related]
4. [Unusual manifestations of Lyme borreliosis. A contribution to the clinical spectrum of this disease group].
Detmar U; Maciejewski W; Link C; Breit R; Sigl H; Robl H; Preac-Mursic V
Hautarzt; 1989 Jul; 40(7):423-9. PubMed ID: 2759856
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous manifestations of Lyme borreliosis. Clinical definitions and differential diagnoses.
Asbrink E
Scand J Infect Dis Suppl; 1991; 77():44-50. PubMed ID: 1947811
[TBL] [Abstract][Full Text] [Related]
6. Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.
Müllegger RR; Means TK; Shin JJ; Lee M; Jones KL; Glickstein LJ; Luster AD; Steere AC
Infect Immun; 2007 Sep; 75(9):4621-8. PubMed ID: 17606602
[TBL] [Abstract][Full Text] [Related]
7. Skin manifestations of lyme borreliosis: diagnosis and management.
Müllegger RR; Glatz M
Am J Clin Dermatol; 2008; 9(6):355-68. PubMed ID: 18973402
[TBL] [Abstract][Full Text] [Related]
8. [Dermatological aspects of Lyme borreliosis].
Lipsker D
Med Mal Infect; 2007; 37(7-8):540-7. PubMed ID: 17391884
[TBL] [Abstract][Full Text] [Related]
9. [Acrodermatitis chronica atrophicans in the course of old Lyme disease].
Zdrodowska A; Zajkowska J; Grygorczuk S; Pancewicz S; Kondrusik M
Pol Merkur Lekarski; 2001 Sep; 11(63):263-5. PubMed ID: 11761826
[TBL] [Abstract][Full Text] [Related]
10. [Guideline 'Lyme borreliosis'].
Speelman P; de Jongh BM; Wolfs TF; Wittenberg J;
Ned Tijdschr Geneeskd; 2004 Apr; 148(14):659-63. PubMed ID: 15106316
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic therapy of Lyme borreliosis].
Satz N; Knoblauch M
Schweiz Med Wochenschr; 1990 Feb; 120(7):209-16. PubMed ID: 2408142
[TBL] [Abstract][Full Text] [Related]
12. Lyme borreliosis.
Melski JW
Semin Cutan Med Surg; 2000 Mar; 19(1):10-8. PubMed ID: 10834603
[TBL] [Abstract][Full Text] [Related]
13. [Stage-oriented treatment of Lyme borreliosis].
Fingerle V; Wilske B
MMW Fortschr Med; 2006 Jun; 148(25):39-41. PubMed ID: 16859159
[TBL] [Abstract][Full Text] [Related]
14. Principles of the diagnosis and antibiotic treatment of Lyme borreliosis.
Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):911-5. PubMed ID: 10666801
[TBL] [Abstract][Full Text] [Related]
15. Lyme borreliosis.
Scarpa C; Trevisan G; Stinco G
Dermatol Clin; 1994 Oct; 12(4):669-85. PubMed ID: 7805296
[TBL] [Abstract][Full Text] [Related]
16. Lyme borreliosis.
Stanek G; Strle F
Lancet; 2003 Nov; 362(9396):1639-47. PubMed ID: 14630446
[TBL] [Abstract][Full Text] [Related]
17. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
18. Lyme disease: European perspective.
Stanek G; Strle F
Infect Dis Clin North Am; 2008 Jun; 22(2):327-39, vii. PubMed ID: 18452805
[TBL] [Abstract][Full Text] [Related]
19. [Lyme borreliosis].
Weber K
Hautarzt; 1986 Nov; 37(11):583-6. PubMed ID: 3542901
[TBL] [Abstract][Full Text] [Related]
20. Contributions to the treatment of dermatologic manifestations of Lyme borreliosis.
Hercogová J; Tománková M; Barták P
Cutis; 1992 Jun; 49(6):409-11. PubMed ID: 1628507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
